2022 annual financial data
Lexaria Bioscience 2022 Operating margin
Direct answer
Operating margin was -2,591.67%.
Operating income was -6,619,039 USD and net income was -7,269,324 USD.
Operating cash flow was -4,879,339 USD.
Get free Lexaria Bioscience email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 255,397 USD
- Operating income
- -6,619,039 USD
- Net income
- -7,269,324 USD
- Operating cash flow
- -4,879,339 USD